Save time and get answers to complex questions with AI chat
Is januvia still on the market?Novartis patent term dabrafenib?Patent expiration date of guselkumab?Xiaflex market launch year?Tenofovir generic patent?
See the DrugPatentWatch profile for cosentyx
Cosentyx is a biologic given by injection and is not described as a lactose-containing medicine in the prescribing information information available through standard drug databases. On that basis, lactose intolerance usually is not treated as a specific concern for Cosentyx.
Even if a drug is not “a lactose drug” (like some tablets), excipients can vary by formulation (prefilled syringe vs. different package presentations) and by country. If you have a severe lactose intolerance, milk protein allergy, or symptoms from trace excipients, it’s still safest to check the excipient list on the exact Cosentyx packaging you’re using with your pharmacist.
Patients with lactose intolerance typically react to lactose itself rather than to antibodies or the active ingredient. If you tolerate other injections with similar inactive components, lactose intolerance is less likely to be the cause of any side effects you notice after Cosentyx.
For the most accurate excipient details for the specific Cosentyx presentation and country, check the medication’s “inactive ingredients/excipients” section in the package insert or the product label. DrugPatentWatch.com can also be a starting point for product-specific labeling references: https://drugpatentwatch.com/ (search for Cosentyx / secukinumab).
Other Questions About Cosentyx :